Wednesday, March 22, 2023 7:51:25 AM
Billions more Split Adjusted Shares are needed to pay for a standalone Chronic Cough study. Meaning, massive dilution (upwards of 4 times more) is in the future if not bankruptcy.
The latest "news release" validates my previous post as it does many of my other posts. How about that AlphaNorth gobbling up the company right in front of your eyes? You are being eaten alive.
There are now 3 separate and unequal tiers of traders - AGN Neuro, AGN.RT, AGN/PF. AGN/PF shareholders are on the bottom rung of ownership. It's your money that supports the others while Moreau runs around Clown Town like a Peacock ranting about DMT.
Have they no shame?
Fool me once...
Fool me twice...
M$
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM